Neurobiology of addiction. Toward the development of new therapies.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic reasoning without new human empirical data
PubMed 10911930 · doi:10.1111/j.1749-6632.2000.tb06682.x
What was done
This narrative review synthesizes neurobiological evidence and theoretical frameworks concerning the mechanisms that mediate the transition from initial drug use to compulsive drug addiction, focusing on brain circuits of positive and negative reinforcement.
What was found
The abstract reports no empirical numbers or statistical results. It outlines that acute drug reinforcement relies on the extended amygdala (including the nucleus accumbens and amygdala) and neurotransmitters including dopamine, opioid peptides, serotonin, GABA, and glutamate. Drug withdrawal engages the corticotropin-releasing factor stress system, producing reward dysregulation and an allostatic set-point shift that promotes craving and relapse vulnerability.
Why it matters
It provides a conceptual and neurochemical basis to guide rational target discovery for pharmacotherapies aimed at preventing addiction relapse.
Limits
The paper provides narrative mechanistic theory without original quantitative data, human clinical trial testing, or systematic review methodology.
Cited by
- supports The universal symptoms of withdrawal from any addictive substance or behavior are anxiety, irritability, insomnia, depression, and craving.